These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 18059149

  • 1. [Influence of the difference in the pollen count on medical costs in an allergen-specific immunotherapy for Japanese cedar pollinosis].
    Yuta A, Miyamoto Y, Hattori R, Ogihara H, Takeuchi K, Majima Y.
    Arerugi; 2007 Nov; 56(11):1366-71. PubMed ID: 18059149
    [Abstract] [Full Text] [Related]

  • 2. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 3. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y, Takahashi Y, Fujita T, Fukuyama S.
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [Abstract] [Full Text] [Related]

  • 4. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K.
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [Abstract] [Full Text] [Related]

  • 5. [Is the frequency of pre-seasonal manifestation in patients with Japanese cedar pollinosis so high?].
    Okuda M, Ohkubo K, Gotoh M, Ishida Y.
    Arerugi; 2005 Jul; 54(7):636-40. PubMed ID: 16229363
    [Abstract] [Full Text] [Related]

  • 6. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
    Horiguchi S, Tanaka Y, Uchida T, Chazono H, Ookawa T, Sakurai D, Okamoto Y.
    Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
    [Abstract] [Full Text] [Related]

  • 7. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
    Kawakami A, Koketsu R, Suzukawa M, Nagao M, Hiraguchi Y, Tokuda R, Fujisawa T, Nagase H, Ohta K, Yamamoto K, Yamaguchi M.
    Int Arch Allergy Immunol; 2008 Mar; 146 Suppl 1():54-60. PubMed ID: 18504408
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H.
    Int Arch Allergy Immunol; 2008 Mar; 146(1):76-84. PubMed ID: 18087165
    [Abstract] [Full Text] [Related]

  • 9. [The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis].
    Yuta A, Ogihara H, Miyamoto Y, Takeuchi K, Okubo K.
    Arerugi; 2010 Nov; 59(11):1552-61. PubMed ID: 21119301
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of efficacy for Japanese cedar pollen-specific immunotherapy by lymphocyte proliferation test].
    Imai T, Nohara O, Katayama N, Endo T, Inoue S, Sakaguchi M, Taniguchi Y, Nakagawa T, Saito S.
    Arerugi; 1996 Nov; 45(11):1172-80. PubMed ID: 8990529
    [Abstract] [Full Text] [Related]

  • 11. [Investigation of trends in patients with pollinosis by using web site and the correlation access number and Japanese cedar pollen counts].
    Ikeda N, Monden A, Ogino S.
    Arerugi; 2005 May; 54(5):464-70. PubMed ID: 16043972
    [Abstract] [Full Text] [Related]

  • 12. Sublingual immunotherapy for Japanese cedar pollinosis.
    Okubo K, Gotoh M.
    Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of clinical efficacy and cost-quality of antihistamines in early treatment for Japanese cedar pollinosis].
    Kakutani C, Ogino S, Ikeda H, Enomoto T.
    Arerugi; 2006 May; 55(5):554-65. PubMed ID: 16883093
    [Abstract] [Full Text] [Related]

  • 14. [One point message of PG-MARJ 2005 (Allergic Rhinitis) treatment of Japanese cedar pollinosis].
    Konno A.
    Arerugi; 2008 Jul; 57(7):817-23. PubMed ID: 18688181
    [No Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092
    [Abstract] [Full Text] [Related]

  • 16. [A long-term follow-up study after discontinuation of immunotherapy for Japanese cedar pollinosis].
    Okuda M.
    Arerugi; 2006 Jun; 55(6):655-61. PubMed ID: 16883102
    [Abstract] [Full Text] [Related]

  • 17. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K.
    Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):185-7. PubMed ID: 16098609
    [Abstract] [Full Text] [Related]

  • 18. [The evaluation of hyposensitization with sugi pollen extracts in patients with nasal allergy to Japanese sugi pollen].
    Ukai K, Amesara R, Masuda S, Nakamato S, Ohkawa C, Okamoto K, Sakakura Y.
    Arerugi; 1994 Feb 18; 43(2 Pt 1):101-5. PubMed ID: 8147711
    [Abstract] [Full Text] [Related]

  • 19. [Japanese cedar pollinosis is a risk factor for bronchial asthma in Japanese adult asthmatics].
    Ueno K, Minoguchi K, Kohno Y, Oda N, Wada K, Miyamoto M, Yokoe T, Hashimoto T, Minoguchi H, Miyamoto M, Yokoe T, Hashimoto T, Minoguchi H, Tanaka A, Kokubu F, Adachi M.
    Arerugi; 2002 Jul 18; 51(7):565-70. PubMed ID: 12201170
    [Abstract] [Full Text] [Related]

  • 20. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
    Ohashi Y.
    Arerugi; 2008 May 18; 57(5):519-23. PubMed ID: 18520172
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.